免疫功能低下的主体肺炎的后果
Benjamin Salwen1, Erica Mascarenhas1, David J Horne2
1Department of Medicine, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA.
免疫功能低下的人面临着肺炎及其并发症的更高风险. 本综述详细介绍了免疫受损宿主肺炎的各种后果,以人类免疫缺陷病毒 (HIV) 患者为模型.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 免疫受损的个体很容易感染机会性感染,如肺炎.
- 肺炎是接受化疗的急性白血病患者死亡的重要原因,也是人类免疫缺陷病毒 (HIV) 感染的早期指标.
- 肺炎后的并发症 (连续症) 是一个问题,特别是在免疫力低下的人群中,因为他们的肺炎风险较高.
研究的目的:
- 审查免疫受损个体中肺炎后续影响的各种并发症,临床表现和器官系统.
- 利用艾滋病毒感染者的良好特征群体作为理解肺炎后果在更广泛的免疫受损群体的模型.
主要方法:
- 文献综述,重点关注免疫受损宿主和肺炎.
- 对各种免疫受损人群中肺炎后并发症的研究进行分析.
- 使用艾滋病毒感染者的案例研究方法来说明常见的后续模式.
主要成果:
- 免疫功能低下的主体的肺炎可能导致影响多个器官系统的广泛并发症.
- 后果因免疫性损害的根本原因和涉及的特定病原体而异.
- 艾滋病毒感染者表现出与肺炎相关的各种后果,突出显示了免疫受损人群的复杂性.
结论:
- 了解肺炎的各种后果对于管理免疫受损患者至关重要.
- 需要进一步的研究,以充分阐明和管理肺炎的长期后果在免疫受损的个体.
- 艾滋病毒感染者作为一种有价值的模型,用于研究不同免疫损害状态的肺炎后果.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
07:43A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice
Published on: September 28, 2016
相关概念视频
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Stages of Infection
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
